全文获取类型
收费全文 | 10105篇 |
免费 | 543篇 |
国内免费 | 78篇 |
专业分类
耳鼻咽喉 | 116篇 |
儿科学 | 226篇 |
妇产科学 | 184篇 |
基础医学 | 1306篇 |
口腔科学 | 240篇 |
临床医学 | 1039篇 |
内科学 | 2414篇 |
皮肤病学 | 112篇 |
神经病学 | 1164篇 |
特种医学 | 352篇 |
外科学 | 1658篇 |
综合类 | 13篇 |
预防医学 | 290篇 |
眼科学 | 105篇 |
药学 | 610篇 |
中国医学 | 12篇 |
肿瘤学 | 885篇 |
出版年
2024年 | 10篇 |
2023年 | 54篇 |
2022年 | 151篇 |
2021年 | 217篇 |
2020年 | 133篇 |
2019年 | 180篇 |
2018年 | 254篇 |
2017年 | 210篇 |
2016年 | 250篇 |
2015年 | 235篇 |
2014年 | 359篇 |
2013年 | 496篇 |
2012年 | 776篇 |
2011年 | 709篇 |
2010年 | 400篇 |
2009年 | 387篇 |
2008年 | 672篇 |
2007年 | 641篇 |
2006年 | 683篇 |
2005年 | 660篇 |
2004年 | 689篇 |
2003年 | 599篇 |
2002年 | 509篇 |
2001年 | 101篇 |
2000年 | 76篇 |
1999年 | 86篇 |
1998年 | 116篇 |
1997年 | 86篇 |
1996年 | 93篇 |
1995年 | 81篇 |
1994年 | 69篇 |
1993年 | 73篇 |
1992年 | 66篇 |
1991年 | 66篇 |
1990年 | 48篇 |
1989年 | 53篇 |
1988年 | 39篇 |
1987年 | 36篇 |
1986年 | 39篇 |
1985年 | 31篇 |
1984年 | 37篇 |
1983年 | 29篇 |
1982年 | 37篇 |
1981年 | 33篇 |
1980年 | 28篇 |
1979年 | 16篇 |
1978年 | 16篇 |
1977年 | 12篇 |
1975年 | 10篇 |
1972年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Ottone T Ammatuna E Lavorgna S Noguera NI Buccisano F Venditti A Giannì L Postorino M Federici G Amadori S Lo-Coco F 《The Journal of molecular diagnostics : JMD》2008,10(3):212-216
Nucleophosmin-1 (NPM1) mutations represent the most frequent gene alteration in acute myeloid leukemia (AML). The most common NPM1 mutation type, accounting for 75 to 80% of cases, is referred to as mutation A (NPM1-mutA). These NPM1 alterations have been shown to possess prognostic significance because they appear to identify patients who will benefit from chemotherapy. Given the high prevalence and stability of these mutations over the course of disease, NPM1 mutations may serve as ideal targets for minimal residual disease (MRD) assessment in AML. Current detection methods are costly, require sophisticated equipment, and are often not sufficiently sensitive. We report here an allele-specific (ASO)-RT-PCR assay that enables rapid and sensitive detection of NPM1-mutA. A semi-nested ASO-PCR method was also designed to increase the sensitivity of our assay for the monitoring of MRD. We analyzed bone marrow cells collected from 52 patients with AML at presentation. NPM1-mutA was detected in leukemic cells from 21 patients. Assay specificity was confirmed by capillary electrophoresis and DNA sequencing. ASO-RT-PCR and semi-nested ASO-PCR assays could detect NPM1-mutA with sensitivities of 10(-2) and 10(-5), respectively. Results obtained here verify that our ASO-RT-PCR assay is a specific and sensitive method for the routine screening of NPM1-mutA, as well as for MRD monitoring of AML patients with this alteration. This method is convenient and easily applicable in countries with limited resources and no access to real-time quantitative PCR-based technologies. 相似文献
993.
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs 总被引:1,自引:0,他引:1
Correale P Del Vecchio MT La Placa M Montagnani F Di Genova G Savellini GG Terrosi C Mannucci S Giorgi G Francini G Cusi MG 《Journal of immunotherapy (Hagerstown, Md. : 1997)》2008,31(2):132-147
The effects of anticancer chemotherapy on antigen-specific cytotoxic T lymphocytes (CTLs) are mostly unknown. We tested the effects of cytotoxic drugs such as 5-fluorouracil, gemcitabine, and oxaliplatin on the functional activity of antigen-specific CTL cultures derived from the peripheral blood mononuclear cells of human donors. We found that a biweekly drug-exposure of human HLA-A(*)02.01+ CTLs derived from bulk cultures led to completely different effects if occurring early (day second) or late (day thirteenth) after the in vitro stimulations with the cognate peptides. In the first case, there was a significant CTL inhibition, whereas in the second, there was a marked enhancement of the antigen-specific cytolytic activity. Results of immunocytofluorimetric studies and CTL/natural killer inhibition assays suggested that the latter effect could be related to a more selective drug-mediated inhibition of cohabitant T regulatory (reg) cells. These results were translated in an in vivo therapeutic mouse model where humanized HLA-A(*)02.01 transgenic mice inoculated with EL-4/humanized HLA-A(*)02.01 transgenic mice showed a prolonged survival and the greatest rate of cure when receiving a combined treatment with a thymidylate synthase-specific peptide vaccine and a multidrug chemotherapy regimen administered late after immunization. Tumor samples derived from this group of mice showed a reduced expression of the target thymidylate synthase antigen, a marked reduction of T(reg)s, and a noteworthy infiltration of C8+ T cells. These results may have clinical implications for the design of new translational anticancer regimens aimed at combining chemotherapy and immunotherapy. 相似文献
994.
D'Alise AM Amabile G Iovino M Di Giorgio FP Bartiromo M Sessa F Villa F Musacchio A Cortese R 《Molecular cancer therapeutics》2008,7(5):1140-1149
The demonstration that the small synthetic molecule reversine [2-(4-morpholinoanilino)-N6-cyclohexyladenine] promotes the dedifferentiation of committed cells into multipotent progenitor-type cells has raised hopes on the exploitation of this small chemical tool for the generation of stem cells. Here, we show that reversine causes a failure in cytokinesis and induces polyploidization. These effects of reversine are due to the inhibition of Aurora A and B, two related kinases that are implicated in several aspects of mitosis and that are frequently amplified and overexpressed in human tumors. Reversine inhibits the phosphorylation of histone H3, a direct downstream target of Aurora kinases. Similarly to the Aurora kinase inhibitor VX-680, which has recently entered phase II clinical trials for cancer treatment, reversine inhibited colony formation of leukemic cells from patients with acute myeloid leukemia but was significantly less toxic than VX-680 on cells from healthy donors. The crystal structure of the reversine-Aurora B kinase complex shows that reversine is a novel class of ATP-competitive Aurora kinase inhibitors. Thus, although our studies raise serious doubts on the application of reversine in regenerative medicine, they support the paradigm that reversine might be a useful agent in cancer chemotherapy. 相似文献
995.
Palese A Beltrame ER Bin A Borghi G Bottacin M Buchini S Buffon ML Carniel G Dal Bo' O De Caneva S De Lucia P Della Bianca S Drusian M Gasti M Giacomuzzi P Labelli E Lavia B Masala O Moretto G Pordenon M Santarossa A Sut A Tomietto M Valoppi G Zorzi MC Guardini I Mesaglio M Vesca R Sbaiz D Salmaso D 《Assistenza infermieristica e ricerca : AIR》2008,27(1):33-42
996.
Rolla S Marchini C Malinarich S Quaglino E Lanzardo S Montani M Iezzi M Angeletti M Ramadori G Forni G Cavallo F Amici A 《Human gene therapy》2008,19(3):229-240
We have shown that electroporation of plasmid carrying extracellular and transmembrane domains (EC-TM plasmid) encoded by the rat neu oncogene triggers a protective immune response toward rat p185(neu)-positive tumors in both wild-type BALB/c mice and cancer-prone rat neu-transgenic BALB-neuT mice. To identify the critical fragments that confer this protective immunity, mice were electroporated with plasmids encoding the TM domain associated with decreasing fragments of the EC domain and the antitumor protection afforded, the titer of antibody, and cytotoxic T lymphocyte (CTL) activity elicited to Neu protein were evaluated. Plasmids encoding EC fragments shortened by 70 (EC1-TM plasmid), 150 (EC2-TM), 230 (EC3-TM), 310 (EC4-TM), and 390 (EC5-TM) NH(2)-terminal residues afforded effective protection. Plasmids encoding shorter truncated proteins were ineffective. When the immunogenic protein was retained in the cytoplasm (EC1-TM, EC2-TM, and EC5-TM), only a CTL response was elicited, whereas when it was also expressed on the membrane (EC4-TM) both CTLs and antibodies were induced. EC4-TM encoding a truncated protein with an EC portion of only 344 amino acids conferred protection on both BALB/c and BALB-neuT mice comparable to that of EC-TM. 相似文献
997.
Circulating plasma factors induce tubular and glomerular alterations in septic burns patients 总被引:1,自引:0,他引:1
Mariano F Cantaluppi V Stella M Romanazzi GM Assenzio B Cairo M Biancone L Triolo G Ranieri VM Camussi G 《Critical care (London, England)》2008,12(2):R42
Background
Severe burn is a systemic illness often complicated by sepsis. Kidney is one of the organs invariably affected, and proteinuria is a constant clinical finding. We studied the relationships between proteinuria and patient outcome, severity of renal dysfunction and systemic inflammatory state in burns patients who developed sepsis-associated acute renal failure (ARF). We then tested the hypothesis that plasma in these patients induces apoptosis and functional alterations that could account for proteinuria and severity of renal dysfunction in tubular cells and podocytes. 相似文献998.
999.
Costa MG Della Rocca G Chiarandini P Mattelig S Pompei L Barriga MS Reynolds T Cecconi M Pietropaoli P 《Intensive care medicine》2008,34(2):257-263
OBJECTIVE: This study aimed to assess the level of agreement of both intermittent cardiac output monitoring by the lithium dilution technique (CO(Li)) and continuous cardiac output monitoring (PulseCO(Li)) using the arterial pressure waveform with intermittent thermodilution using a pulmonary artery catheter (CO(PAC)). DESIGN: Prospective, single-center evaluation. SETTING: University Hospital Intensive Care Unit. PATIENTS: Patients (n=23) receiving liver transplantation. INTERVENTION: Pulmonary artery catheters were placed in all patients and CO(PAC) was determined using thermodilution. CO(Li) and PulseCO(Li) measurements were made using the LiDCO system. MEASUREMENTS AND MAIN RESULTS: Data were collected after intensive care unit admission and every 8h until the 48th hour. A total of 151 CO(PAC), CO(Li) and PulseCO(Li) measurements were analysed. Bias and 95% limit of agreement were 0.11lmin(-1) and -1.84 to + 2.05 lmin(-1) for CO(PAC) vs. CO(Li) (r=0.88) resulting in an overall percentage error of 15.6%. Bias and 95% limit of agreement for CO(PAC) vs. PulseCO(Li) were 0.29 lmin(-1) and -1.87 to + 2.46 lmin(-1) (r=0.85) with a percentage error of 16.8%. Subgroup analysis revealed a percentage error of 15.7% for CO(PAC) vs. CO(Li) and 15.1% for CO(PAC) vs. PulseCO(Li) for data pairs less than 8 lmin(-1), and percentage errors of 15.5% and 18.5% respectively for data pairs higher than 8 lmin(-1). CONCLUSION: In patients with hyperdynamic circulation, intermittent and continuous CO values determined using the LiDCO system showed good agreement with those obtained by intermittent pulmonary artery thermodilution. 相似文献
1000.